These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
91 related items for PubMed ID: 7986586
1. HIV type 1 infection of CD4+ T cells depends critically on basic amino acid residues in the V3 domain of envelope glycoprotein 120. Okada T, Patterson BK, Otto PA, Gurney ME. AIDS Res Hum Retroviruses; 1994 Jul; 10(7):803-11. PubMed ID: 7986586 [Abstract] [Full Text] [Related]
2. Single basic amino acid substitutions at position 302 or 320 in the V3 domain of HIV type 1 are not sufficient to alter the antiviral activity of dextran sulfate and heparin. Okada T, Gurney ME. AIDS Res Hum Retroviruses; 1995 May; 11(5):571-5. PubMed ID: 7576913 [Abstract] [Full Text] [Related]
3. Studies on the role of the V3 loop in human immunodeficiency virus type 1 envelope glycoprotein function. Chiou SH, Freed EO, Panganiban AT, Kenealy WR. AIDS Res Hum Retroviruses; 1992 Sep; 8(9):1611-8. PubMed ID: 1457207 [Abstract] [Full Text] [Related]
4. Functional complementation of the envelope hypervariable V3 loop of human immunodeficiency virus type 1 subtype B by the subtype E V3 loop. Sato H, Kato K, Takebe Y. Virology; 1999 May 10; 257(2):491-501. PubMed ID: 10329559 [Abstract] [Full Text] [Related]
5. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. Fouchier RA, Groenink M, Kootstra NA, Tersmette M, Huisman HG, Miedema F, Schuitemaker H. J Virol; 1992 May 10; 66(5):3183-7. PubMed ID: 1560543 [Abstract] [Full Text] [Related]
6. Patterns of amino acid variability in NSI-like and SI-like V3 sequences and a linked change in the CD4-binding domain of the HIV-1 Env protein. Milich L, Margolin BH, Swanstrom R. Virology; 1997 Dec 08; 239(1):108-18. PubMed ID: 9426451 [Abstract] [Full Text] [Related]
7. Amino acid substitutions in the human immunodeficiency virus type 1 gp120 V3 loop that change viral tropism also alter physical and functional properties of the virion envelope. Willey RL, Theodore TS, Martin MA. J Virol; 1994 Jul 08; 68(7):4409-19. PubMed ID: 7515973 [Abstract] [Full Text] [Related]
8. Amino acid substitutions in the V3 loop are responsible for adaptation to growth in transformed T-cell lines of a primary human immunodeficiency virus type 1. Harrowe G, Cheng-Mayer C. Virology; 1995 Jul 10; 210(2):490-4. PubMed ID: 7618285 [Abstract] [Full Text] [Related]
9. Replacement of the V3 region of gp120 with SDF-1 preserves the infectivity of T-cell line-tropic human immunodeficiency virus type 1. Yonezawa A, Hori T, Takaori-Kondo A, Morita R, Uchiyama T. J Virol; 2001 May 10; 75(9):4258-67. PubMed ID: 11287575 [Abstract] [Full Text] [Related]
10. Analysis of mutations in the V3 domain of gp160 that affect fusion and infectivity. Page KA, Stearns SM, Littman DR. J Virol; 1992 Jan 10; 66(1):524-33. PubMed ID: 1727497 [Abstract] [Full Text] [Related]
11. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1. Borbe HC, Stuber G, Wagner R, Wolf H, Modrow S. J Pept Sci; 1995 Jan 10; 1(2):109-23. PubMed ID: 9222988 [Abstract] [Full Text] [Related]
12. Restricted variable residues in the C-terminal segment of HIV-1 V3 loop regulate the molecular anatomy of CCR5 utilization. Hu Q, Napier KB, Trent JO, Wang Z, Taylor S, Griffin GE, Peiper SC, Shattock RJ. J Mol Biol; 2005 Jul 22; 350(4):699-712. PubMed ID: 15964018 [Abstract] [Full Text] [Related]
13. Characterization of HIV type 1 from Romanian children: lack of correlation between V3 loop amino acid sequence and syncytium formation in MT-2 cells. Holm-Hansen C, Grothues D, Rustad S, Røsok B, Pascu FR, Asjö B. AIDS Res Hum Retroviruses; 1995 May 22; 11(5):597-603. PubMed ID: 7576916 [Abstract] [Full Text] [Related]
14. [Molecular analysis of the principal neutralization epitope (V3 loop) of human immunodeficiency virus type 1 in Argentina]. Gómez Carrillo M, Piccardo C, Libonatti O. Rev Argent Microbiol; 1992 May 22; 24(2):91-101. PubMed ID: 1298019 [Abstract] [Full Text] [Related]
16. Alteration of HIV-1 infectivity and neutralization by a single amino acid replacement in the V3 loop domain. Ivanoff LA, Looney DJ, McDanal C, Morris JF, Wong-Staal F, Langlois AJ, Petteway SR, Matthews TJ. AIDS Res Hum Retroviruses; 1991 Jul 22; 7(7):595-603. PubMed ID: 1768461 [Abstract] [Full Text] [Related]
17. Development of resistance of human immunodeficiency virus type 1 to dextran sulfate associated with the emergence of specific mutations in the envelope gp120 glycoprotein. Este JA, Schols D, De Vreese K, Van Laethem K, Vandamme AM, Desmyter J, De Clercq E. Mol Pharmacol; 1997 Jul 22; 52(1):98-104. PubMed ID: 9224818 [Abstract] [Full Text] [Related]
18. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein. Peet NM, McKeating JA, de Souza JB, Roitt IM, Delves PJ, Lund T. Virology; 1998 Nov 10; 251(1):59-70. PubMed ID: 9813203 [Abstract] [Full Text] [Related]
19. Blood monocytes infected in vivo by HIV-1 variants with a syncytium-inducing phenotype. Innocenti-Francillard P, Brengel K, Guillon C, Mallet F, Morand P, Gruters R, Seigneurin JM. AIDS Res Hum Retroviruses; 1994 Jun 10; 10(6):683-90. PubMed ID: 8074932 [Abstract] [Full Text] [Related]
20. Evidence for the cooperation of gp120 amino acids 322 and 448 in SIVmac entry. Morrison HG, Kirchhoff F, Desrosiers RC. Virology; 1993 Jul 10; 195(1):167-74. PubMed ID: 8317093 [Abstract] [Full Text] [Related] Page: [Next] [New Search]